Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer

被引：0
|
作者：
M F E Godinho
A M Sieuwerts
M P Look
D Meijer
J A Foekens
L C J Dorssers
T van Agthoven
机构：
[1] Josephine Nefkens Institute,Department of Pathology
[2] Erasmus MC-University Medical Center Rotterdam,Department of Medical Oncology
[3] Josephine Nefkens Institute,undefined
[4] Erasmus MC-University Medical Center Rotterdam,undefined
[5] Cancer Genomics Center,undefined
[6] Josephine Nefkens Institute,undefined
[7] Erasmus MC-University Medical Center Rotterdam,undefined
来源：
British Journal of Cancer | 2010年 / 103卷
关键词：
tamoxifen resistance; endocrine therapy; BCAR4; ERBB2; ERBB3; ERBB4;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1284 / 1291
页数：7
相关论文
共 50 条
  • [21] RETRACTED ARTICLE: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
    Tangwei Wu
    Xiaoyi Li
    Ge Yan
    Zheqiong Tan
    Dan Zhao
    Shuiyi Liu
    Hui Wang
    Yuan Xiang
    Weiqun Chen
    Hongda Lu
    Xinghua Liao
    Yong Li
    Zhongxin Lu
    [J]. Journal of Experimental & Clinical Cancer Research, 42
  • [22] LncRNA BCAR4 expression predicts the clinical response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Gan, Feng-Jiao
    Li, Yi
    Xu, Meng-Xi
    Zhou, Tie
    Wu, Shun
    Hu, Kang
    Li, Yan
    Sun, Su-Hong
    Luo, Qing
    [J]. CANCER BIOMARKERS, 2021, 32 (03) : 339 - 351
  • [23] The role of long non-coding RNA BCAR4 in human cancers
    Qiong Yi
    Zhongcheng Liu
    Kun Zhang
    Xuening Liu
    Lifu Wang
    Bin Geng
    Yayi Xia
    [J]. Human Cell, 2021, 34 : 1301 - 1309
  • [24] RETRACTED: BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients (Retracted Article)
    Wang, L.
    Chunyan, Q.
    Zhou, Y.
    He, O.
    Ma, Y.
    Ga, Y.
    Wang, X.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (18) : 4064 - 4070
  • [25] The role of long non-coding RNA BCAR4 in human cancers
    Yi, Qiong
    Liu, Zhongcheng
    Zhang, Kun
    Liu, Xuening
    Wang, Lifu
    Geng, Bin
    Xia, Yayi
    [J]. HUMAN CELL, 2021, 34 (05) : 1301 - 1309
  • [26] BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients (vol 21, pg 4064, 2017)
    Wang, L.
    Chunyan, Q.
    Zhou, Y.
    He, Q.
    Ma, Y.
    Ga, Y.
    Wang, X.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (07) : 2822 - 2822
  • [27] Up-regulated BCAR4 contributes to proliferation and migration of cervical cancer cells
    Zou, Ruanmin
    Chen, Xiangjian
    Jin, Xuejing
    Li, Shi
    Ou, Rongying
    Xue, Jisen
    Yan, Xiaojian
    Chen, Lulu
    Hu, Yan
    Zhu, Hua
    [J]. SURGICAL ONCOLOGY-OXFORD, 2018, 27 (02): : 306 - 313
  • [28] LncRNA BCAR4 promotes colon cancer progression via activating Wnt/β-catenin signaling
    Ouyang, Shurui
    Zheng, Xinbin
    Zhou, Xin
    Chen, Zhengquan
    Yang, Xuefeng
    Xie, Ming
    [J]. ONCOTARGET, 2017, 8 (54) : 92815 - 92826
  • [29] LncRNA BCAR4 up-regulates EGFR and thus promotes human thyrocyte proliferation
    Zhai, H. Y.
    Yan, R. H.
    Yang, T. Z.
    Zhou, Z. H.
    Gao, I
    Li, J.
    [J]. NEOPLASMA, 2019, 66 (02) : 222 - 231
  • [30] Tamoxifen Resistance in Breast Cancer
    Chang, Minsun
    [J]. BIOMOLECULES & THERAPEUTICS, 2012, 20 (03) : 256 - 267
12345